Looking forward to the @CureParkinsonsT Autumn Research Update meeting; It is FREE (virtual & in-person); Come along & learn what we are funding in #Parkinsons research (big theme for this meeting will be MAMS - multi-arm, multi-stage trial platforms) https://t.co/NJkyVCHpaW

Researchers present the core clinical features associated with survival in patients with Dementia with Lewy Bodies https://t.co/DYFFqcCUpx

New review article explores targeting metabotropic glutamate receptors for symptomatic & disease-modifying treatment in #Parkinsons https://t.co/StVZtz46YK

“CDC will have lost its ability to detect outbreaks & respond to them. It will no longer be able to track diseases, in America & around the globe. That includes infectious threats like flu, foodborne illnesses & Ebola, and chronic diseases & injuries." https://t.co/CbHgsxZq4A

Everything you ever wanted to know about mitochondria-associated membranes - a new review explores molecular organization, cellular functions, & their role in health + disease (#Parkinsons get a few mentions) https://t.co/kR8tA5wQBs

Looking for a top of the line dash cam? Protect you from potential legal or financial troubles? I got you!

Using an unbiased FACS-based genome-wide CRISPR/Cas9 knockout screen, researchers identify key genes & pathways specifically implicated in α-syn PFFs intracellular accumulation, including heparan sulfate proteoglycans biosynthesis & Golgi trafficking https://t.co/cseN0vAUjq

Researchers present a novel lncRNA FAM151B-DT that regulates degradation of aggregation prone proteins; Silencing FAM151B-DT in vitro is sufficient to enhance tau & #Parkinsons-associated α-synuclein aggregation https://t.co/aTcqfwRA3W

The age association aspect of #Parkinsons does not get enough attention. Now @Mitochondri_Al @DrouinOuellet @HeatherMortiboy & colleagues provide a consistent framework to enhance research reproducibility, investigating the nexus of ageing & PD https://t.co/RJ6typxIjX

The U.S. Constitution has 4,400 words. It is the oldest and shortest written Constitution of any major government in the world. You can read and understand the entire U.S. Constitution in graphic novel form.

Interesting: LRRK2 inhibitors for #Alzheimers? Researchers report LRRK2 deficiency mitigates amyloid β deposition-mediated pathology in a mouse model of AD (by reprogramming microglia) https://t.co/Qujxmhzi4B

Last week Herantis Pharma @HerantisPharma presented positive topline data from their Phase 1b trial of small peptide molecule HER-096 (designed to mimic the activity of cerebral dopamine neurotrophic factor; CDNF) in people with #Parkinsons at MDS2025 https://t.co/vY3y5rv1uu

The new tube map of London - called the "Expobiome map"

Meta-metabolomics?!? Ok If that is what it takes Researchers identify 11 metabolites that are differentially abundant between #Parkinsons (n=50), prodromal PD (n=30) & control cases (n=50); β-glutamate⬆️in PD and prodromal PD https://t.co/9kUPbS90Tb

"Civilization is the only example of super intelligence." Our CEO @davidpstout on @startupprojectt explaining why we're building millions of specialized models across devices — not one giant model in the cloud. A few highlights: – Why prompting loses money – 8B models matching

Curiously, dopamine agonist-treated cases of restless leg syndrome (n = 3077) showed a significantly longer restricted mean survival time to #Parkinsons diagnosis, compared to controls

New retrospective cohort study using Korean National Health Insurance Service data (2002 to 2019) finds restless leg syndrome is associated with an increased risk of developing #Parkinsons; N=9919 patients with RLS & 9919 matched controls https://t.co/eFYdEMbl5J

FFS @ScienceofPD @moversand6 @morethanatremor Novo Nordisk shuts cell therapy unit amid restructuring -

New research from @AkcimenFulya @sarabandres1 & colleagues (basically everyone) presents a comprehensive genetic catalog of both known & novel coding & splicing variants potentially linked to #Parkinsons etiology in 710 African cases (& 11k controls) https://t.co/0Vu4oz5s5u

The Wire tracks every move in college sports—are you keeping up?

Check out our new paper on the genetics of Parkinson’s disease in African and African-admixed populations, now published in Brain. https://t.co/NZGnbT11R6

Oh look! Speaking of combos A new funding opportunity to explore rationally designed combination therapies in #Parkinsons How interesting! https://t.co/OMchyix5Jx

Combination therapies! #Alzheimers is doing it, why isn't #Parkinsons? Human transcriptomic & drug repurposing analyses identify letrozole & irinotecan for AD; Medical records=⬇️lower AD risk in people exposed to letrozole or irinotecan; Rescues AD models https://t.co/JAHgv5hKl3

BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”

🎙️ Investor Spotlight: Why Calidi Biotherapeutics $CLDI Is a Company to Watch Eric Poma, PhD, CEO of @CalidiBio, breaks down the company’s innovative approach to fighting cancer using proprietary stem cell-based platforms to deliver powerful oncolytic viruses. Why It Matters